$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.

2021 Q2 Form 10-Q Financial Statement

#000182323921000021 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $217.8M $46.91M
YoY Change 364.29%
Cost Of Revenue $37.81M $21.20M
YoY Change 78.38%
Gross Profit $180.0M $25.71M
YoY Change 600.03%
Gross Profit Margin 82.64% 54.81%
Selling, General & Admin $24.50M $15.99M
YoY Change 53.24%
% of Gross Profit 13.61% 62.19%
Research & Development $1.929M $1.600M
YoY Change 20.56%
% of Gross Profit 1.07% 6.22%
Depreciation & Amortization $1.615M $1.434M
YoY Change 12.62%
% of Gross Profit 0.9% 5.58%
Operating Expenses $26.43M $17.59M
YoY Change 50.27%
Operating Profit $153.5M $8.120M
YoY Change 1790.83%
Interest Expense $7.649M $7.463M
YoY Change 2.49%
% of Operating Profit 4.98% 91.91%
Other Income/Expense, Net -$3.000K $20.00K
YoY Change -115.0%
Pretax Income $145.9M $677.0K
YoY Change 21448.45%
Income Tax $11.39M -$765.0K
% Of Pretax Income 7.8% -113.0%
Net Earnings $49.14M $1.423M
YoY Change 3353.48%
Net Earnings / Revenue 22.57% 3.03%
Basic Earnings Per Share $0.44 $0.00
Diluted Earnings Per Share $0.44 $0.00
COMMON SHARES
Basic Shares Outstanding 112.2M shares 253.9M shares
Diluted Shares Outstanding 112.3M shares 253.9M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.7M
YoY Change
Cash & Equivalents $374.7M $84.46M
Short-Term Investments
Other Short-Term Assets $138.5M
YoY Change
Inventory $47.78M
Prepaid Expenses
Receivables $83.53M
Other Receivables $0.00
Total Short-Term Assets $644.5M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $104.8M
YoY Change
Goodwill $152.8M
YoY Change
Intangibles $125.1M
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.026M
YoY Change
Total Long-Term Assets $956.8M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $644.5M
Total Long-Term Assets $956.8M
Total Assets $1.601B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.70M
YoY Change
Accrued Expenses $24.79M
YoY Change
Deferred Revenue $109.5M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $6.000M
YoY Change
Total Short-Term Liabilities $164.8M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $526.6M
YoY Change
Other Long-Term Liabilities $1.057M
YoY Change
Total Long-Term Liabilities $527.6M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $164.8M
Total Long-Term Liabilities $527.6M
Total Liabilities $1.268B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $74.77M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $193.9M
YoY Change
Total Liabilities & Shareholders Equity $1.601B
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $49.14M $1.423M
YoY Change 3353.48%
Depreciation, Depletion And Amortization $1.615M $1.434M
YoY Change 12.62%
Cash From Operating Activities $165.3M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$4.265M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $48.00K
YoY Change
Cash From Investing Activities -$4.317M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.99M
YoY Change
NET CHANGE
Cash From Operating Activities 165.3M
Cash From Investing Activities -4.317M
Cash From Financing Activities -33.99M
Net Change In Cash 127.0M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $165.3M
Capital Expenditures -$4.265M
Free Cash Flow $169.6M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
MRVI
dei Entity Central Index Key
EntityCentralIndexKey
0001823239
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Entity File Number
EntityFileNumber
001-39725
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Maravai LifeSciences Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2786970
dei Entity Address Address Line1
EntityAddressAddressLine1
10770 Wateridge Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
546-0004
dei Security12b Title
Security12bTitle
Class A common stock, $0.01 par value
CY2021Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
125034000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83534000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51018000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11095000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
47781000 USD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash
Cash
374710000 USD
CY2020Q4 us-gaap Cash
Cash
236184000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
33301000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13432000 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
644491000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
331598000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104751000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101305000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
152766000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
224275000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
125116000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
177656000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
570097000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
431699000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4026000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4158000 USD
CY2021Q2 us-gaap Assets
Assets
1601247000 USD
CY2020Q4 us-gaap Assets
Assets
1270691000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11704000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8171000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24794000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38546000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
109490000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
78061000 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1298000 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2021Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
11487000 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164773000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
130778000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
526583000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528614000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8609000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
193921000 USD
CY2021Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
55626000 USD
CY2020Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
56167000 USD
CY2021Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
520067000 USD
CY2020Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
389546000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1057000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2231000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1268106000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1115945000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118208000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85125000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-44000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
73176000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
854000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
88511000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
139220000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
66235000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
333141000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
154746000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1601247000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1270691000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217775000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46905000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365986000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97886000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
37513000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
21197000 USD
us-gaap Cost Of Revenue
CostOfRevenue
67881000 USD
us-gaap Cost Of Revenue
CostOfRevenue
36494000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1932000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1600000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4096000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32114000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5344000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24085000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15988000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47322000 USD
CY2021Q2 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
CY2020Q2 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
19002000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
63530000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
38785000 USD
us-gaap Costs And Expenses
CostsAndExpenses
119299000 USD
us-gaap Costs And Expenses
CostsAndExpenses
54950000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
154245000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8120000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
246687000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
42936000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
8512000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
7463000 USD
us-gaap Interest Expense
InterestExpense
17282000 USD
us-gaap Interest Expense
InterestExpense
14845000 USD
CY2021Q2 us-gaap Related Party Tax Expense Effect Of Change In Allocation Methodology
RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology
0 USD
CY2020Q2 us-gaap Related Party Tax Expense Effect Of Change In Allocation Methodology
RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology
0 USD
us-gaap Related Party Tax Expense Effect Of Change In Allocation Methodology
RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology
-5886000 USD
us-gaap Related Party Tax Expense Effect Of Change In Allocation Methodology
RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology
0 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145730000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
677000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
235291000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28191000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11386000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-765000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25095000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2870000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
134344000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1442000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
85269000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
137874000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
509000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
49075000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1423000 USD
us-gaap Net Income Loss
NetIncomeLoss
72322000 USD
us-gaap Net Income Loss
NetIncomeLoss
24812000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112203530 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104467998 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112280375 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253916941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257685618 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253916941 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
134344000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1442000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
134352000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1452000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
210212000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
25260000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
85274000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
19000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
137885000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
509000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49078000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1433000 USD
CY2021Q2 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2383000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33075000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
72327000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24751000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
209756000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
CY2021Q2 mrvi Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact
AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact
18940000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
785000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
134344000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
333141000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
154746000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 USD
mrvi Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact
AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact
18940000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
785000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16000 USD
us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4661000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
56203000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
333141000 USD
CY2020Q1 us-gaap Members Equity
MembersEquity
168943000 USD
CY2020Q2 us-gaap Limited Liability Company Llc Members Equity Unit Based Compensation
LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation
576000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
190000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1442000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000 USD
CY2020Q2 us-gaap Members Equity
MembersEquity
170781000 USD
CY2019Q4 us-gaap Members Equity
MembersEquity
144627000 USD
us-gaap Limited Liability Company Llc Members Equity Unit Based Compensation
LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation
1084000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
190000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61000 USD
CY2020Q2 us-gaap Members Equity
MembersEquity
170781000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
us-gaap Depreciation
Depreciation
4151000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18211000 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
19002000 USD
us-gaap Depreciation
Depreciation
3125000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10081000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10116000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1319000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
862000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4661000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1084000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1274000 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2881000 USD
us-gaap Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
162000 USD
us-gaap Interest Expense Lessee Assets Under Capital Lease
InterestExpenseLesseeAssetsUnderCapitalLease
615000 USD
mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
5886000 USD
mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
389000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-414000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36471000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9742000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18073000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7923000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5013000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
257000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4085000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3419000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13916000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2415000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-771000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
31430000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10045000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
204547000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21328000 USD
mrvi Payments To Acquire Assets Net Of Cash Acquired
PaymentsToAcquireAssetsNetOfCashAcquired
0 USD
mrvi Payments To Acquire Assets Net Of Cash Acquired
PaymentsToAcquireAssetsNetOfCashAcquired
3024000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7782000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6468000 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
548000 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
34500000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7234000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25008000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
56203000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
190000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
365000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
77000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1018000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58550000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13483000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-61000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
138776000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
59758000 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-250000 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
0 USD
mrvi Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Excluding Assets Held For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectExcludingAssetsHeldForSale
138526000 USD
mrvi Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Excluding Assets Held For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectExcludingAssetsHeldForSale
59758000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236184000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24700000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
374710000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84458000 USD
us-gaap Interest Paid Net
InterestPaidNet
15547000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Interest Paid Net
InterestPaidNet
11780000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
9087000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1360000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3242000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
137706000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
mrvi Conversion Of Stock Deferred Tax Asset
ConversionOfStockDeferredTaxAsset
156647000 USD
mrvi Conversion Of Stock Deferred Tax Asset
ConversionOfStockDeferredTaxAsset
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue and expenses, and related disclosures. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. Significant estimates include, but are not limited to, revenue recognition, the net realizable value of inventory, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets, estimated fair values of intangible assets and goodwill, the payable to related parties pursuant to the Tax Receivable Agreement (“TRA”), amortization methods and periods, the fair value of leased buildings and other assumptions associated with lease financing transactions, the estimated fair value of our long-term debt, equity-based compensation, the valuation of incentive units, allowance for doubtful accounts, and accounting for income taxes and assessment of valuation allowances. Actual results could differ materially from those estimates.</span></div>
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
200000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
111300000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79200000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217775000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365986000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46905000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97886000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217775000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46905000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365986000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97886000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2021Q2 us-gaap Goodwill
Goodwill
152800000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
224300000 USD
us-gaap Number Of Reporting Units
NumberOfReportingUnits
4 reportingUnit
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskFinancial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains the majority of its cash balances at multiple financial institutions that management believes are of high credit-quality and financially stable. Cash is deposited with major financial institutions in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash is held. The Company provides credit, in the normal course of business, to international and domestic distributors and customers, which are geographically dispersed. The Company attempts to limit its credit risk by performing ongoing credit evaluations of its customers and maintaining adequate allowances for potential credit losses.
CY2020Q4 us-gaap Goodwill
Goodwill
224275000 USD
us-gaap Goodwill Transfers
GoodwillTransfers
-71509000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
152766000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
196477000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
71361000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
125116000 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y6M
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
264217000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86561000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
177656000 USD
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y1M6D
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14417000 USD
CY2021Q2 mrvi Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
59720000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
125116000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7545000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
14600000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14417000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14417000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12084000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18448000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
18497000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11112000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22999000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18333000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6285000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3856000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
47781000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
33301000 USD
CY2021Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2379000 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2896000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1800000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7670000 USD
CY2021Q2 mrvi Contract With Customer Liability Current Deposits
ContractWithCustomerLiabilityCurrentDeposits
1707000 USD
CY2020Q4 mrvi Contract With Customer Liability Current Deposits
ContractWithCustomerLiabilityCurrentDeposits
1091000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1448000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2290000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5376000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6151000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24794000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38546000 USD
mrvi Lessee Operating Lease Number Of Facilities Leased
LesseeOperatingLeaseNumberOfFacilitiesLeased
5 segment
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000.0 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2000000.0 USD
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000 USD
CY2020Q1 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
34500000 USD
CY2020Q2 us-gaap Sale Leaseback Transaction Deferred Gain Gross
SaleLeasebackTransactionDeferredGainGross
3100000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2197000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
484000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
4648000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1273000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5014000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1336000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5109000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1371000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5071000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
550000000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1104000 USD
CY2021Q2 mrvi Capital Leases Future Minimum Payments Due After Four Years
CapitalLeasesFutureMinimumPaymentsDueAfterFourYears
24272000 USD
CY2021Q2 mrvi Operating Leases Future Minimum Payments Due After Four Years
OperatingLeasesFutureMinimumPaymentsDueAfterFourYears
5286000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
46311000 USD
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10854000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
26165000 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
20146000 USD
CY2021Q2 mrvi Capital Leases Residual Value
CapitalLeasesResidualValue
36563000 USD
CY2021Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1083000 USD
CY2021Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
55626000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
400000000.0 USD
CY2020Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
50000000.0 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
547000000 USD
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14417000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15386000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
532583000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
534614000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
526583000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528614000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6000000 USD
CY2021Q2 mrvi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
520000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
547000000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
21600000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2383000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
576000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4661000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1084000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
mrvi Preferred Units Cumulative Annual Dividend Percentage
PreferredUnitsCumulativeAnnualDividendPercentage
0.080
mrvi Preferred Units Cumulative Annual Dividend Additional Rate Percentage
PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage
0.040
mrvi Preferred Units Cumulative Annual Dividend Additional Rate Percentage
PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage
0.040
CY2021Q2 us-gaap Profit Loss
ProfitLoss
134344000 USD
mrvi Net Income Loss Attributable To Common Noncontrolling Interest
NetIncomeLossAttributableToCommonNoncontrollingInterest
-51000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49075000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
207000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
72322000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1442000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2020Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1530000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3060000 USD
CY2021Q2 mrvi Net Income Loss Attributable To Common Noncontrolling Interest
NetIncomeLossAttributableToCommonNoncontrollingInterest
85269000 USD
CY2020Q2 mrvi Net Income Loss Attributable To Common Noncontrolling Interest
NetIncomeLossAttributableToCommonNoncontrollingInterest
-295000 USD
mrvi Net Income Loss Attributable To Common Noncontrolling Interest
NetIncomeLossAttributableToCommonNoncontrollingInterest
137874000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
72322000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22312000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49075000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
207000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
177185000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22312000 USD
CY2021Q2 us-gaap Dilutive Securities
DilutiveSecurities
19000 USD
CY2020Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
us-gaap Dilutive Securities
DilutiveSecurities
21000 USD
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2021Q2 mrvi Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock
DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock
0 USD
CY2020Q2 mrvi Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock
DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock
0 USD
mrvi Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock
DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock
104842000 USD
mrvi Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock
DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock
0 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
49094000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
207000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22312000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112203530 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104467998 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112203530 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104467998 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
253916941 shares
CY2021Q2 mrvi Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
0 shares
CY2020Q2 mrvi Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
0 shares
mrvi Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
153165971 shares
mrvi Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112280375 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253916941 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257685618 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
253916941 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
144952455 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14245000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1648472 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14245000 shares
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145730000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
677000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
235291000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28191000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11386000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-765000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25095000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2870000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.078
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.130
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.107
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.102
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.078
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.107
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.130
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.102
mrvi Assumed Effective Income Tax Rate Reconciliation Percent
AssumedEffectiveIncomeTaxRateReconciliationPercent
0.467
mrvi Assumed Effective Income Tax Rate Reconciliation Business Income Deduction Unavailable Percent
AssumedEffectiveIncomeTaxRateReconciliationBusinessIncomeDeductionUnavailablePercent
0.541
CY2021Q2 mrvi Tax Distribution Payable
TaxDistributionPayable
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217775000 USD
CY2021Q2 mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
164721000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33100000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
56200000 USD
mrvi Tax Receivable Agreement Percentage Of Tax Benefits Paid
TaxReceivableAgreementPercentageOfTaxBenefitsPaid
0.85
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
521400000 USD
mrvi Tax Receivable Agreement Percentage Of Tax Benefits Paid
TaxReceivableAgreementPercentageOfTaxBenefitsPaid
0.85
CY2021Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
383700000 USD
CY2021Q1 mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
5900000 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1300000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
365986000 USD
mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
266653000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46905000 USD
CY2020Q2 mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
17514000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97886000 USD
mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
47065000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
134344000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
1442000 USD
us-gaap Profit Loss
ProfitLoss
210196000 USD
us-gaap Profit Loss
ProfitLoss
25321000 USD
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5040000 USD
CY2020Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5041000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
10081000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
10116000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
2297000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
1434000 USD
us-gaap Depreciation
Depreciation
4151000 USD
us-gaap Depreciation
Depreciation
3125000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
8512000 USD
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
13000 USD
CY2020Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
2913000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
7463000 USD
us-gaap Interest Expense
InterestExpense
17282000 USD
us-gaap Interest Expense
InterestExpense
14845000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11386000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-765000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25095000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2870000 USD
CY2021Q2 mrvi Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
161579000 USD
CY2020Q2 mrvi Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
14615000 USD
mrvi Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
266805000 USD
mrvi Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
56277000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
-798000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
3602000 USD
CY2021Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
1049000 USD
CY2020Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
0 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
1049000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
0 USD
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2020Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2881000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2383000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
576000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4661000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1084000 USD
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
0 USD
CY2020Q2 us-gaap Management Fee Expense
ManagementFeeExpense
218000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
0 USD
us-gaap Management Fee Expense
ManagementFeeExpense
429000 USD
CY2021Q2 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
CY2020Q2 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
47065000 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
19002000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
997000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-808000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1916000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
94000 USD
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
798000 USD
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
0 USD
us-gaap Professional Fees
ProfessionalFees
1004000 USD
us-gaap Professional Fees
ProfessionalFees
1700000 USD
CY2021Q2 mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
0 USD
CY2020Q2 mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
0 USD
mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
5886000 USD
mrvi Gain Loss On Tax Receivable Agreement
GainLossOnTaxReceivableAgreement
0 USD
CY2021Q2 mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
164721000 USD
CY2020Q2 mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
17514000 USD
mrvi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
266653000 USD

Files In Submission

Name View Source Status
0001823239-21-000021-index-headers.html Edgar Link pending
0001823239-21-000021-index.html Edgar Link pending
0001823239-21-000021.txt Edgar Link pending
0001823239-21-000021-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrvi-20210630.htm Edgar Link pending
mrvi-20210630.xsd Edgar Link pending
mrvi-20210630_cal.xml Edgar Link unprocessable
mrvi-20210630_def.xml Edgar Link unprocessable
mrvi-20210630_g1.jpg Edgar Link pending
mrvi-20210630_htm.xml Edgar Link completed
mrvi-20210630_lab.xml Edgar Link unprocessable
mrvi-20210630_pre.xml Edgar Link unprocessable
mrvi-q22021form10xqxex311x.htm Edgar Link pending
mrvi-q22021form10xqxex312x.htm Edgar Link pending
mrvi-q22021xform10xqxex321.htm Edgar Link pending
mrvi-q22021xform10xqxex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending